NDC 68180-348-01 - Gabapentin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 68180-348
Requested NDC: 68180-348-01
Package NDCs from labels: 68180-348-01, 68180-348-02
Manufacturer: Lupin Pharmaceuticals, Inc. | LUPIN LIMITED
Effective date: 2018-09-04
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Gabapentin - Lupin Pharmaceuticals, Inc. \| LUPIN LIMITED	Lupin Pharmaceuticals, Inc. \| LUPIN LIMITED	2018-09-04	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68180-348-01	Gabapentin	100 in 1 BOTTLE	TABLET, FILM COATED	100		7
68180-348-02	Gabapentin	500 in 1 BOTTLE	TABLET, FILM COATED	500		7

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68180-348	GABAPENTIN TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.]	7	2 package rows	20180905_d53b9838-f47a-40df-bf6d-71e7166b6101.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 19 of 21 · 401 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Gabapentin	GABAPENTIN	Asclemed USA, Inc.	14b1840d-a2db-4eec-bc25-029e35b042e4	2022-07-09	Warnings, Adverse reactions	Exact identifier unii: 6CW7F3G59X
Gabapentin	GABAPENTIN	Asclemed USA, Inc.	c18d9d06-f796-4eb7-8fd5-1de4ebb95439	2022-07-07	Warnings, Adverse reactions	Exact identifier rxcui: 310433 unii: 6CW7F3G59X
GABAPENTIN	GABAPENTIN	Aphena Pharma Solutions - Tennessee, LLC	17988b64-723c-488d-befd-3e4e4cc44bd2	2022-05-11	Warnings, Adverse reactions	Exact identifier rxcui: 310434 unii: 6CW7F3G59X
Gabapentin	GABAPENTIN	Proficient Rx LP	ed22b78e-93ff-4cb5-9c9c-2afe9b60dd2e	2022-05-02	Warnings, Adverse reactions	Exact identifier unii: 6CW7F3G59X
Gabapentin	GABAPENTIN	Proficient Rx LP	645824d0-eb3d-442b-806d-36a70796cb8e	2022-05-01	Warnings, Adverse reactions	Exact identifier unii: 6CW7F3G59X
GABAPENTIN	GABAPENTIN	Proficient Rx LP	aa3ab216-372a-4a72-bfd1-88a1ffa31ba3	2022-05-01	Warnings, Adverse reactions	Exact identifier unii: 6CW7F3G59X
Gabapentin	GABAPENTIN	Proficient Rx LP	b67b7865-df64-429a-9550-5333b9c713ea	2022-04-01	Warnings, Adverse reactions	Exact identifier rxcui: 310433 rxcui: 310434 unii: 6CW7F3G59X
Gabapentin	GABAPENTIN	Proficient Rx LP	223a9216-6e07-49b9-8faf-bb4e529a6ae5	2022-04-01	Warnings, Adverse reactions	Exact identifier unii: 6CW7F3G59X
Gabapentin	GABAPENTIN	Proficient Rx LP	2fb2233f-9152-4630-ab39-51a0cda7e5ca	2022-04-01	Warnings, Adverse reactions	Exact identifier rxcui: 310433 unii: 6CW7F3G59X
Gabapentin	GABAPENTIN	Proficient Rx LP	52af51ab-6543-466b-848c-13c588c98789	2022-04-01	Warnings, Adverse reactions	Exact identifier unii: 6CW7F3G59X
Gabapentin	GABAPENTIN	Proficient Rx LP	2b76955c-52a4-4026-b286-3da1112fe989	2022-04-01	Warnings, Adverse reactions	Exact identifier rxcui: 310434 unii: 6CW7F3G59X
gabapentin	GABAPENTIN	Aphena Pharma Solutions - Tennessee, LLC	7790d906-af26-4e60-bc6f-e906ec03cc24	2022-03-21	Warnings, Adverse reactions	Exact identifier rxcui: 310433 unii: 6CW7F3G59X
GABAPENTIN	GABAPENTIN	Aphena Pharma Solutions - Tennessee, LLC	7f579665-afb7-4227-98c1-2eafee650504	2022-02-28	Warnings, Adverse reactions	Exact identifier rxcui: 310433 unii: 6CW7F3G59X
GABAPENTIN	GABAPENTIN	Proficient Rx LP	185f264e-db32-41cd-b90d-519717b97850	2021-11-01	Warnings, Adverse reactions	Exact identifier unii: 6CW7F3G59X
Gabapentin	GABAPENTIN	Amneal Pharmaceuticals of New York LLC	b11dbff5-ceee-4a63-a093-f6efebdc2f6f	2021-02-03	Warnings, Adverse reactions	Exact identifier unii: 6CW7F3G59X
dd706d74-7d10-4ef0-b474-7a8bfb2fea93			d53b9838-f47a-40df-bf6d-71e7166b6101	2021-02-01	Warnings, Adverse reactions	Exact identifier spl set id: d53b9838-f47a-40df-bf6d-71e7166b6101
Gabapentin	GABAPENTIN	Proficient Rx LP	f6baeb5c-ca9c-4730-aeb8-8f8732e8ca3a	2021-01-01	Warnings, Adverse reactions	Exact identifier rxcui: 310433 unii: 6CW7F3G59X
Gabapentin	GABAPENTIN	Proficient Rx LP	c79d94ec-117d-4fb6-845d-1954e3472bb0	2021-01-01	Warnings, Adverse reactions	Exact identifier rxcui: 310434 unii: 6CW7F3G59X
Gabapentin	GABAPENTIN	Aphena Pharma Solutions - Tennessee, LLC	3b4395f2-9440-4b67-97cc-5d16f3bdd05e	2020-08-14	Warnings, Adverse reactions	Exact identifier unii: 6CW7F3G59X
Gabapentin	GABAPENTIN	Aphena Pharma Solutions - Tennessee, LLC	39149f0e-30ed-4671-8be7-2a484f65d63b	2020-08-05	Warnings, Adverse reactions	Exact identifier rxcui: 310433 unii: 6CW7F3G59X

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.